Science-first advisory, built from the inside out
CellGene Nexus was founded by scientists who saw the regulatory gauntlet firsthand — and decided there had to be a better way.
Why we started
Too many promising biotech programs stall not because the science fails, but because the regulatory strategy wasn't built in from day one. Founders and CSOs find themselves deep in IND preparation with no clear roadmap, misaligned CMC packages, and a clock ticking on runway.
CellGene Nexus was created to close that gap. Our team works in precision oncology, translational research, and early-phase clinical trials every day, so we know where programs tend to stall and how to plan around it.
We built the firm we wished more early-stage programs had access to.
To accelerate the path from discovery to clinic by embedding rigorous regulatory thinking into the earliest stages of biotech development — so that science-driven founders can move faster, with confidence.
What guides us
Science integrity first
Every recommendation we make is grounded in the data. We never let regulatory convenience override scientific truth.
Founder-aligned perspective
We think like operators, not consultants. We understand the pressure of runway, board timelines, and the weight of a program's first human dose.
Proactive, not reactive
The best regulatory strategy is one built before the first FDA question arrives. We help clients get ahead of risk, not just respond to it.
Transparent partnership
No black-box advice. We explain our reasoning, share our frameworks, and build your team's capability alongside your program.
What makes CellGene Nexus different
- Deep bench experience across gene therapy, cell therapy, and biologics
- Integrated CMC, nonclinical, and clinical regulatory strategy under one roof
- Embedded advisory model — we work as an extension of your team, not a vendor
- Track record of successful IND submissions and FDA meeting outcomes
Ready to build your regulatory strategy?
Let's talk about where your program is and where it needs to go.
Book a Discovery Call